NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
COCP Cocrystal Pharma
- 2.2500
- +0.1500+7.14%
Close Dec 20 16:00 ET
- 2.2470
- -0.0030-0.13%
Post 20:01 ET
22.89MMarket Cap-1.22P/E (TTM)
2.3300High2.0205Low64.01KVolume2.1199Open2.1000Pre Close139.44KTurnover0.91%Turnover RatioLossP/E (Static)10.17MShares3.100052wk High1.80P/B15.78MFloat Cap1.325052wk Low--Dividend TTM7.01MShs Float77.4000Historical High--Div YieldTTM14.74%Amplitude1.3250Historical Low2.1780Avg Price1Lot Size
Cocrystal Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -91.09%-5.12M | 33.33%-3.7M | -44.74%-4.5M | 31.58%-14.67M | 32.03%-3.33M | 69.90%-2.68M | -48.98%-5.55M | 20.43%-3.11M | -62.97%-21.44M | -45.80%-4.89M |
| Net income from continuing operations | -18.58%-4.94M | -28.25%-5.34M | 23.76%-3.96M | 53.69%-17.98M | 0.82%-4.46M | 26.93%-4.17M | 82.95%-4.17M | -23.31%-5.19M | -173.79%-38.84M | -22.14%-4.5M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 75.51%-12K | --0 |
| Depreciation and amortization | -8.33%99K | 36.13%211K | -28.57%35K | -457.73%-1.39M | -1,800.00%-1.7M | 10.20%108K | 63.16%155K | -48.42%49K | 1.57%388K | 3.09%100K |
| Other non cash items | -21.05%-69K | ---- | ---- | 847.85%1.56M | 3,254.55%1.74M | -9.62%-57K | ---- | ---- | -187.45%-209K | -114.29%-55K |
| Change In working capital | -137.06%-467K | 184.82%1.36M | -142.52%-739K | 186.36%2.34M | 258.56%945K | 136.31%1.26M | -220.47%-1.6M | 6,852.00%1.74M | -1,695.29%-2.71M | -835.80%-596K |
| -Change in receivables | 392.45%1.04M | -457.22%-693K | 52.92%-113K | 75.70%-174K | 52.51%-340K | -34.97%212K | 159.51%194K | ---240K | -228.78%-716K | -12,033.33%-716K |
| -Change in prepaid assets | -166.06%-144K | 646.34%1.22M | 957.89%201K | 128.06%470K | -86.78%69K | 109.57%218K | 127.78%164K | 137.50%19K | -891.12%-1.68M | 201.73%522K |
| -Change in payables and accrued expense | ---- | ---- | -145.03%-883K | 737.38%2.05M | 402.49%1.22M | ---- | ---- | 11,435.29%1.96M | -47.93%-321K | -310.20%-402K |
| -Change in other current assets | ---- | ---- | 61.11%87K | ---- | ---- | ---- | ---- | --54K | ---- | ---- |
| -Change in other current liabilities | ---- | ---- | 44.64%-31K | ---- | ---- | ---- | ---- | ---56K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -91.09%-5.12M | 33.33%-3.7M | -44.74%-4.5M | 31.58%-14.67M | 32.03%-3.33M | 69.90%-2.68M | -48.98%-5.55M | 20.43%-3.11M | -68.53%-21.44M | -67.45%-4.89M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 82.22%-8K | -59.46%-118K | -391.67%-59K | 0 | -14K | -45K | -42.31%-74K | -50.00%-12K |
| Net PPE purchase and sale | --0 | --0 | 82.22%-8K | -59.46%-118K | -391.67%-59K | --0 | ---14K | ---45K | -42.31%-74K | -50.00%-12K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 82.22%-8K | -59.46%-118K | -391.67%-59K | --0 | ---14K | ---45K | -42.31%-74K | -50.00%-12K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 14,888.89%3.99M | 0 | 0 | 57,242.86%4M | -16.67%-7K | -100.07%-27K | 22.22%-7K |
| Net issuance payments of debt | --0 | --0 | --0 | 74.07%-7K | --0 | --0 | --0 | -16.67%-7K | 30.77%-27K | 22.22%-7K |
| Net common stock issuance | --0 | ---- | ---- | --4M | --0 | --0 | ---- | ---- | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | 14,888.89%3.99M | --0 | --0 | 57,242.86%4M | -16.67%-7K | -100.07%-27K | 22.22%-7K |
| Net cash flow | ||||||||||
| Beginning cash position | -43.93%18.22M | -35.64%21.92M | -28.99%26.43M | -36.65%37.22M | -29.24%29.81M | -36.42%32.49M | -37.90%34.06M | -36.65%37.22M | 77.72%58.76M | -31.71%42.13M |
| Current changes in cash | -91.09%-5.12M | -136.81%-3.7M | -42.62%-4.51M | 49.89%-10.79M | 31.78%-3.39M | 69.97%-2.68M | 58.13%-1.56M | 19.23%-3.16M | -183.81%-21.54M | -68.83%-4.96M |
| End cash Position | -56.08%13.1M | -43.93%18.22M | -35.64%21.92M | -28.99%26.43M | -28.99%26.43M | -29.24%29.81M | -36.42%32.49M | -37.90%34.06M | -36.65%37.22M | -36.65%37.22M |
| Free cash flow | -91.09%-5.12M | 33.50%-3.7M | -42.93%-4.51M | 31.27%-14.78M | 30.99%-3.39M | 70.11%-2.68M | -49.36%-5.56M | 19.28%-3.16M | -68.42%-21.51M | -67.41%-4.91M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.